Erzincan Binali Yıldırım ÜniversitesiErzincan Binali Yıldırım ÜniversitesiAçık Erişim Arşivi · RDL Open

Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127] (International Immunopharmacology (2021) 100, (S1567576921007633), (10.1016/j.intimp.2021.108127))

CorrectionAçık Erişim

Özet

The author regrets that the following ethical approval number is missing from the article: 27/06/2021, Ref. No. 11-13. The authors would like to apologise for any inconvenience caused. © 2024 Elsevier B.V.

Anahtar Kelimeler

erratumhumanmiddle ageddrug developmentnonhumanpharmacology
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11460Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorHuyut, Zübeyir
dc.date.accessioned2026-10-18T20:26:30.191904877Z
dc.date.available2026-10-18T20:26:30.191904877Z
dc.date.issued2024
dc.description.abstractThe author regrets that the following ethical approval number is missing from the article: 27/06/2021, Ref. No. 11-13. The authors would like to apologise for any inconvenience caused. © 2024 Elsevier B.V.
dc.identifier.doi10.1016/j.intimp.2024.113650
dc.identifier.eissn1878-1705
dc.identifier.issn1567-5769
dc.identifier.issuePt 3
dc.identifier.pmid39578122
dc.identifier.scopus2-s2.0-85210096599
dc.identifier.startpage113650
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11460
dc.identifier.volume143
dc.identifier.wosWOS:001376781600001
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Immunopharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjecterratum
dc.subjecthuman
dc.subjectmiddle aged
dc.subjectdrug development
dc.subjectnonhuman
dc.subjectpharmacology
dc.titleCorrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127] (International Immunopharmacology (2021) 100, (S1567576921007633), (10.1016/j.intimp.2021.108127))
dc.typeCorrection
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.wos0
rdl.departmentDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Erzincan Binali Yıldırım University, 24100 Erzincan, Turkey. Electronic address: tahir.huyut@erzincan.edu.tr.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)